iothalamic acid has been researched along with Lymphoma, Non-Hodgkin in 1 studies
Iothalamic Acid: A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine (IOTHALAMATE MEGLUMINE) salts.
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graebner, HF | 1 |
| Bayindir, S | 1 |
1 trial available for iothalamic acid and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
[Tolerance of modern contrast media in urologic roentgen diagnosis].
Topics: Adult; Aged; Clinical Trials as Topic; Contrast Media; Drug Hypersensitivity; Dysgerminoma; Female; | 1970 |